Zdrowie i gospodarka · 29/03/2000
FDA Announces Draft Guidance for Industry on Clinical Trials Data Bank for Serious or Life-Threatening Diseases
The FDA has released a draft guidance outlining recommendations for pharmaceutical companies to submit clinical trial data for serious or life-threatening diseases to a data bank developed by the National Library of Medicine at the National Institutes of Health, in compliance with the Food and Drug Administration Modernization Act.